麻豆传媒

Isaac Yang, M.D., is a nationally renowned neurosurgeon specializing in brain tumors, superior semicircular canal dehiscence (SSCD), and skull base brain surgery at UCLA. Yang is a board-certified neurosurgeon and director of medical student education for the UCLA Department of Neurosurgery; an associate professor of neurosurgery, head and neck surgery, and radiation oncology at the David Geffen School of Medicine at UCLA, and a principal investigator at the UCLA brain tumor laboratory.  
 
Yang is highly sought out by peers, patients and the media for his expertise in neurological diseases and brain health. He has made multiple TV appearances on Good Morning America, CBS' The Doctors, Dr. Drew LifeChangers, and several national news outlets. Originally from Lodi, Calif., Yang developed an interest in neurobiology as an undergraduate. He earned his bachelor鈥檚 degree with Phi Beta Kappa from the University of California, Berkeley.  His training followed with a medical degree from the David Geffen School of Medicine at UCLA.  Yang completed a neurological surgery residency at the University of California San Francisco, as well as an NRSA NIH-funded F32 postdoctoral brain tumor research fellowship.
 
Yang鈥檚 clinical focus has been primarily on brain tumors, both glioblastoma and skull base tumors.  His research efforts have examined antigen expression and manipulation of the immune response to glioblastoma. His work was recognized by a UCSF Clinical and Translational Scientist Training Award and the CNS Dandy Clinical Research Fellowship.  Yang has been the recipient of several distinguished regional and national awards, including the UCSF Medical Center 2010 Exceptional Physician Award, the AANS Integra Brain Tumor Research Award, San Francisco Neurological Society Edwin Boldrey Award for Basic Science Research, American Academy of Neurological and Orthopedic Surgeons Research Award, Kaiser Award for Clinical Research, the national AANS Leksell Radiosurgery Award, and the Tumor Section Ronald L. Bittner Award on Brain Tumor Research.  
 
Yang has published more than 150 publications in peer-reviewed journals and authored more than half a dozen book chapters.  At UCLA, he is investigating the use of nanoparticles and nanotechnology for their application in brain tumor immunotherapy and vaccines.  Dr. Isaac Yang is dedicated to improving the care and treatment of all patients undergoing neurosurgery. 
 
If interested please follow Dr. Yang on Facebook at Isaac Yang UCLA Neurosurgery or find his most recent book, Service Minded Physician, on Amazon.

Dr. Moliterno is a board certified, fellowship trained neurosurgeon specialized in the surgical treatment of all types of primary brain tumors, including gliomas (GBMs, oligodendrogliomas, astrocytomas), meningiomas and acoustic neuromas (vestibular schwannomas), as well as other relatively less common tumor types (medulloblastoma, pineal tumors, intraventricular tumors, epidermoid tumors, etc). She performs the highest volume of brain tumor surgery in the state of Connecticut and routinely cares for patients seeking second or third opinions from afar. Dr. Moliterno has particular expertise in the treatment of complex brain tumors with the safe and effective use of more sophisticated microsurgical techniques, such as functional brain mapping and awake craniotomy for tumors located in highly functioning brain (i.e. speech and motor) areas, as well as those arising along the skull base. Given her skull base surgical specialization, she also routinely performs microvascular decompression for trigeminal neuralgia and hemifacial spasm. Dr. Moliterno is credentialed for performing gamma knife radiosurgery.
Dr. Moliterno serves as the Clinical Director for the Chenevert Family Brain Tumor Center and Chief of Neurosurgical Oncology in the Department of Neurosurgery. She is also the Director of the Multidisciplinary Brain Tumor Board and Precision Brain Tumor Board and the Director for the Neurosurgical Oncology Fellowship Program. She serves as Chair of the Lovemark Foundation Fund at Smilow Cancer Hospital, aimed at providing support for patients with brain tumors.
Dr. Moliterno鈥檚 research interests parallel that of her clinical practice with a bench-to-bedside focus on the clinical implications of the genomics of brain tumors.
She completed her internship and residency training in neurosurgery at Yale New Haven Hospital and clinical fellowship in neurosurgical oncology at the Memorial Sloan-Kettering Cancer Center.

Education & Training
MD
University of Florida College of Medicine (2005)
Fellowship
Memorial Sloan Kettering Cancer Center
Residency
Yale-New Haven Hospital
Internship
Yale-New Haven Hospital

, is a board-certified neurosurgeon who specializes in complex cranial surgery, endovascular neurosurgery, stroke care, and neurological oncology. He is chair of the Department of Neurological Surgery at UC San Diego Health and professor of neurological surgery, radiology and neurosciences and the Don and Karen Cohn Chancellor's Endowed Chair in Neurosurgery at UC San Diego School of Medicine.
Khalessi provides both open surgical and minimally invasive, catheter-based approaches to complex neurosurgical conditions, including brain tumors, aneurysms, arteriovenous malformations (AVM), carotid disease and ischemic stroke.
Khalessi is a founding member of the Medical Device Innovation Consortium (MDIC) that advises the FDA on early clinical feasibility for emerging neurovascular devices. He serves on the NIH Interventional Advisory Panel for StrokeNet, which provides scientific oversight for federally funded research in neurovascular disease.

, is a board-certified neurosurgeon who is an internationally renowned expert on the treatment of patients with acoustic neuromas, skull base tumors, and neurofibromatosis type 2 (NF2). He is also the recognized neurosurgical leader in the field of auditory brainstem implants. In addition, Dr. Schwartz treats complex cranial problems, meningiomas, brain tumors, pituitary tumors, cranial nerve disorders, and intradural spine tumors.
Schwartz conducts research in tumor biology and genetics, especially in relation to schwannomas and neurofibromatosis type 2. He is a national leader in the development and refinement of the auditory brainstem implant, which is used for hearing restoration in deaf adults and children who are unable to benefit from hearing aids or cochlear implants.
He is a frequent speaker at national and international conferences and has been a visiting professor at medical schools on three continents.